Crystalys Therapeutics does not yet have data from pivotal tests of its gout drug, but the company is already looking ahead to potentially bringing the drug to the market, plans …
Health
-
-
Candid Health, a revenue cycle management platform, announced Wednesday that it raised $120 million in Series D funding. San Francisco-based Candid Health serves medical groups, managed service organizations and digital …
-
The federal government is right to ask hard questions about psychiatric prescribing. Every patient deserves treatment that is evidence-based, individualized, and free from unnecessary medications. But if the national conversation …
-
Revenue integrity is one of those areas that everyone agrees is important, but very few organizations feel like they have fully under control. At a high level, the idea sounds …
-
Within the next three to five years, the drug pipeline is expected to continue to boom with specialty medications dominating the list. Specialty medications are high-cost prescription medications used to …
-
Healthcare venture investing has always been a competition to identify the best companies. This next decade will belong to the investors identifying the best breakthroughs before they become companies at …
-
Nearly no one got into the business of health care because they want to think about identity. But AI is making us all rethink healthcare, and quickly. And identity is …
-
Drug research continues to churn out new advances, some that are potential cures. But even though more than $800 billion a year is spent on pharmaceuticals, many Americans either don’t …
-
Digital health investors have heard nearly every founder pitch imaginable, including many that start along the lines of “healthcare is broken, and I’m the one who’s going to fix it.” …
-
Priority Health, a Michigan-based insurer, announced Wednesday that it has launched two new cancer support solutions for employers in partnership with Color Health and Grail. The insurer serves more than …